{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T21:47:33Z","timestamp":1747172853178,"version":"3.40.5"},"reference-count":13,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:00:00Z","timestamp":1611792000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Infect. Control Hosp. Epidemiol."],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S0899823X20012854_as1\"><jats:title>Objective:<\/jats:title><jats:p>To determine the usefulness of adjusting antibiotic use (AU) by prevalence of bacterial isolates as an alternative method for risk adjustment beyond hospital characteristics.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X20012854_as2\"><jats:title>Design:<\/jats:title><jats:p>Retrospective, observational, cross-sectional study.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X20012854_as3\"><jats:title>Setting:<\/jats:title><jats:p>Hospitals in the southeastern United States.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X20012854_as4\"><jats:title>Methods:<\/jats:title><jats:p>AU in days of therapy per 1,000 patient days and microbiologic data from 2015 and 2016 were collected from 26 hospitals. The prevalences of <jats:italic>Pseudomonas aeruginosa,<\/jats:italic> extended-spectrum \u03b2-lactamase (ESBL)\u2013producing bacteria, methicillin-resistant <jats:italic>Staphylococcus aureus<\/jats:italic> (MRSA), and vancomycin-resistant enterococci (VRE) were calculated and compared to the average prevalence of all hospitals in the network. This proportion was used to calculate the adjusted AU (a-AU) for various categories of antimicrobials. For example, a-AU of antipseudomonal \u03b2-lactams (APBL) was the AU of APBL divided by (prevalence of <jats:italic>P. aeruginosa<\/jats:italic> at that hospital divided by the average prevalence of <jats:italic>P. aeruginosa<\/jats:italic>). Hospitals were categorized by bed size and ranked by AU and a-AU, and the rankings were compared.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X20012854_as5\"><jats:title>Results:<\/jats:title><jats:p>Most hospitals in 2015 and 2016, respectively, moved \u22652 positions in the ranking using a-AU of APBL (15 of 24, 63%; 22 of 26, 85%), carbapenems (14 of 23, 61%; 22 of 25; 88%), anti-MRSA agents (13 of 23, 57%; 18 of 26, 69%), and anti-VRE agents (18 of 24, 75%; 15 of 26, 58%). Use of a-AU resulted in a shift in quartile of hospital ranking for 50% of APBL agents, 57% of carbapenems, 35% of anti-MRSA agents, and 75% of anti-VRE agents in 2015 and 50% of APBL agents, 28% of carbapenems, 50% of anti-MRSA agents, and 58% of anti-VRE agents in 2016.<\/jats:p><\/jats:sec><jats:sec id=\"S0899823X20012854_as6\"><jats:title>Conclusions:<\/jats:title><jats:p>The a-AU considerably changes how hospitals compare among each other within a network. Adjusting AU by microbiological burden allows for a more balanced comparison among hospitals with variable baseline rates of resistant bacteria.<\/jats:p><\/jats:sec>","DOI":"10.1017\/ice.2020.1285","type":"journal-article","created":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T08:20:06Z","timestamp":1611822006000},"page":"688-693","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["Novel method of calculating adjusted antibiotic use by microbiological burden"],"prefix":"10.1017","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6203-6522","authenticated-orcid":false,"given":"Hana R.","family":"Winders","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6501-492X","authenticated-orcid":false,"given":"Majdi N.","family":"Al-Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darrell T.","family":"Childress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kayla R.","family":"Stover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin B.","family":"Britt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias B.","family":"Chahine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suetping","family":"Lau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela D.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shauna Jacobson","family":"Junco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah H.","family":"Wrenn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad J.","family":"Crane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan R.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan M.","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8806-4583","authenticated-orcid":false,"given":"Christopher M.","family":"Bland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn H.","family":"MacVane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geneen M.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-0963","authenticated-orcid":false,"given":"P. Brandon","family":"Bookstaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"S0899823X20012854_ref12","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1127"},{"key":"S0899823X20012854_ref9","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881100001X"},{"key":"S0899823X20012854_ref4","unstructured":"4. New antimicrobial stewardship standard. The Joint Commission website. https:\/\/www.jointcommission.org\/-\/media\/enterprise\/tjc\/imported-resource-assets\/documents\/new_antimicrobial_stewardship_standardpdf.pdf?db=web&hash=69307456CCE435B134854392C7FA7D76#:~:text=The%20Joint%20Commission%20recently%20announced,becomes%20effective%20January%201%2C%202017. Published July 2016. Accessed February 21, 2019."},{"key":"S0899823X20012854_ref2","unstructured":"2. The core elements of antibiotic stewardship for nursing homes. Centers for Disease Control and Prevention website. www.cdc.gov\/longtermcare\/index.html. Published 2015. Accessed October 2020."},{"key":"S0899823X20012854_ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40506-014-0015-3"},{"key":"S0899823X20012854_ref1","unstructured":"1. Core elements of hospital antibiotic stewardship programs. Centers for Disease Control and Prevention website. www.cdc.gov\/getsmart\/healthcare\/implementation\/core-elements.html. Published 2014. Accessed October 2020."},{"key":"S0899823X20012854_ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy075"},{"key":"S0899823X20012854_ref13","first-page":"1","article-title":"MRSA prevalence and hospital-level antibiotic use: a retrospective study across 122 acute-care hospitals","author":"Livorsi","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"key":"S0899823X20012854_ref11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy354"},{"key":"S0899823X20012854_ref10","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.1995.1.219"},{"key":"S0899823X20012854_ref5","doi-asserted-by":"publisher","DOI":"10.1086\/511640"},{"key":"S0899823X20012854_ref3","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6506a1"},{"key":"S0899823X20012854_ref8","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8030127"}],"container-title":["Infection Control &amp; Hospital Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0899823X20012854","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,10]],"date-time":"2021-06-10T12:42:41Z","timestamp":1623328961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0899823X20012854\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0899823X20012854"],"URL":"https:\/\/doi.org\/10.1017\/ice.2020.1285","relation":{},"ISSN":["0899-823X","1559-6834"],"issn-type":[{"type":"print","value":"0899-823X"},{"type":"electronic","value":"1559-6834"}],"subject":[],"published":{"date-parts":[[2021,1,28]]},"assertion":[{"value":"\u00a9 The Author(s), 2021. Published by Cambridge University Press on behalf of The Society for Healthcare Epidemiology of America","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}